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a b s t r a c t
A large number of imaging studies have examined the neural correlates of consummatory pleasure and
anticipatory pleasure in schizophrenia, but the brain regions where schizophrenia patients consistently
demonstrate dysfunctions remain unclear. We performed a series of meta-analyses on imaging studies to
delineate the regions associated with consummatory and anticipatory pleasure dysfunctions in
schizophrenia. Nineteen functional magnetic resonance imaging or positron emission tomography
studies using whole brain analysis were identiﬁed through a literature search (PubMed and EBSCO;
January 1990–February 2014). Activation likelihood estimation was performed using the GingerALE
software. The clusters identiﬁed were obtained after controlling for the false discovery rate at po0.05
and applying a minimum cluster size of 200 mm3. It was found that schizophrenia patients exhibited
decreased activation mainly in the rostral medial prefrontal cortex (rmPFC), the right parahippocampus/
amygala, and other limbic regions (e.g., the subgenual anterior cingulate cortex, the putamen, and the
medial globus pallidus) when consummating pleasure. Task instructions (feeling vs. stimuli) were
differentially related to medial prefrontal dysfunction in schizophrenia. When patients anticipated
pleasure, reduced activation in the left putamen was observed, despite the limited number of studies.
Our ﬁndings suggest that the medial prefrontal cortex and limbic regions may play an important role in
neural dysfunction underlying deﬁcits in consummatory pleasure in schizophrenia.
& 2015 Elsevier Ireland Ltd. All rights reserved.
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1. Introduction
Anhedonia, deﬁned as the inability to experience pleasure, is a core
feature of negative symptoms in schizophrenia (Andreason, 1983;
Pelizza and Ferrari, 2009). Functional imaging studies have provided
researchers the opportunity to examine the neural correlates asso-
ciated with hedonic experience in schizophrenia (Knutson and Greer,
2008; Kringelbach and Berridge, 2009). Pleasure experience is widely
accepted as a construct involving two distinct components, anticipa-
tory pleasure (deﬁned as the emotional state in anticipation of future
pleasurable events) and consummatory pleasure (deﬁned as the
emotional state while experiencing pleasurable events) (Gard et al.,
2006; Knutson and Greer, 2008; Kringelbach and Berridge, 2009).
Different brain regions have been proposed to be responsible for these
two components (Knutson and Greer, 2008; Kringelbach and Berridge,
2009). Speciﬁcally, the ventral striatum (VS) and the ventral tegmental
area (VTA) are thought to be primarily responsible for anticipatory
(Berridge and Robinson, 1998; de Haan et al., 2004; Knutson and
Greer, 2008), while the medial prefrontal cortex (mPFC) and the
amygdala are thought to be associated with consummatory pleasure
(Knutson et al., 2003; Knutson and Greer, 2008).
For consummatory pleasure, the ﬁndings in previous imaging
studies provided a mixed picture of mPFC and amygdala activation
in schizophrenia patients (Crespo-Facorro et al., 2001; Paradiso et
al., 2003; Schlagenhauf et al., 2009; Waltz et al., 2009; Dowd and
Barch, 2010; Ursu et al., 2011). For example, some studies reported
that patients with schizophrenia exhibited reduced activation in
the mPFC in response to the delivery of juice (Waltz et al., 2009),
pleasurable odour (Crespo-Facorro et al., 2001) and positive
pictures (Paradiso et al., 2003). However, Dowd and Barch (2010)
did not ﬁnd this impairment in schizophrenia patients who
viewed positively valenced pictures, faces and words. Likewise,
several imaging studies reported that patients with schizophrenia
exhibited attenuated activation in bilateral amygdala when they
were presented with pictures of happy faces and pleasurable
odours (Gur et al., 2002; Schneider et al., 2007; Gradin et al.,
2011). However, two other studies found enhanced activation in
bilateral amygdala in patients with schizophrenia during the
processing of positive affective pictures (Paradiso et al., 2003;
Reske et al., 2007).
For anticipatory pleasure, more and more studies in recent
years have examined striatal activation associated with the expec-
tation of positive events in patients with schizophrenia. Previous
imaging studies in clinical samples suggest that when compared
with healthy controls, patients with schizophrenia showed
decreased ventral striatal activation in anticipation of reward
(Juckel et al., 2006a, 2006b; Schlagenhauf et al., 2008, 2009).
Another imaging study reported reduced activation in the dorsal
striatum (i.e., the putamen) when schizophrenia patients were
presented with unexpected juice deliveries (Waltz et al., 2009).
However, these ﬁndings have not always been consistent. Some
studies only reported reduced activation in the unilateral ventral
striatum (left or right) (Juckel et al., 2006a, 2006b; Schlagenhauf
et al., 2008) in schizophrenia patients relative to healthy controls.
Another study has suggested reduced activation in bilateral ventral
striatum in schizophrenia (Schlagenhauf et al., 2009). One study
found enhanced activation in this region (Gradin et al., 2011)
during expectation of rewarding stimuli. However, other studies
did not ﬁnd any difference in ventral striatal activation between
schizophrenia patients and healthy controls (Walter et al., 2009;
Simon et al., 2010; Waltz et al., 2010).
To the best of our knowledge, although there have been several
recent narrative reviews on the neural mechanism of hedonic
experience in patients with schizophrenia (Andreasen et al., 1997;
Abler et al., 2008; Craig, 2009; Barch and Dowd, 2010; Kring and
Caponigro, 2010), few meta-analyses have been carried out to
quantitatively examine the neural correlates associated with
hedonic experience. For example, the question of whether there
exist brain regions consistently reﬂecting impairment in response
to positive stimuli in schizophrenia is unresolved. Furthermore, we
know little about the exact neural basis of anticipatory and
consummatory pleasure dysfunction in schizophrenia (Kring and
Barch, 2014). One recent meta-analysis demonstrated that patients
with schizophrenia showed reduced activation in response to
emotional experience in the left occipital pole compared with
healthy controls (Taylor et al., 2012). However, the authors mainly
focused their attention on negative emotions rather than positive
emotions, and hedonic experience, which may be elicited by
reward stimuli (Knutson and Greer, 2008; Kringelbach and
Berridge, 2009), was not investigated. Therefore, in the present
study, we aimed to perform an objective, systematic and quanti-
tative analysis of the imaging literature using activation likelihood
estimation (ALE) to investigate the neural correlates of anticipa-
tory and consummatory pleasure in schizophrenia.
Meanwhile, since different tasks and stimuli were used and
different types of patients (e.g., with regard to medication status
and severity of negative symptoms) were recruited in different
studies, we have further examined whether these confounding
factors affected the ALE ﬁndings.
2. Methods
2.1. Selection of articles
PubMed and EBSCO (PsycARTICLES, PsycINFO, PsycEXTRA, PsycCRITIQUES)
online database searches were conducted between January 1990 and February
2014. Search terms included “emotion,” “emotional experience,” “affective experi-
ence,” “pleasure,” “anhedonia”, “positive emotion”, “positive affect”, “reward”, and
C. Yan et al. / Psychiatry Research: Neuroimaging 231 (2015) 187–196188
“happiness”, with different combinations of “schizophrenn” and “brain mapping”,
“fMRI” or “PET”. Six hundred and seven articles were identiﬁed through the
literature search. Eleven articles were added based on our previous meta-analysis
(Yan et al., 2012). Thus, a total of 618 articles were identiﬁed.
Articles were excluded according to the following criteria (see Fig. 1):
(1) Articles that appeared more than once (270 articles excluded).
(2) Articles that were not experimental reports or not published in peer-reviewed
journals (143 articles excluded).
(3) Articles not written in English (ﬁve articles excluded).
(4) Paradigms that did not capture emotional experience using fMRI (functional
magnetic resonance imaging) or PET (positron emission tomography) (108
articles excluded).
(5) Articles not reporting the coordinates of neural activation associated with
hedonic experience (i.e., positive condition–neutral condition) (26 articles
excluded).
(6) Articles that did not focus on schizophrenia patients (22 articles excluded).
(7) The data of the articles were either not available or not applicable (i.e., studies
reporting results using correlation analysis (Harvey et al., 2010) or functional
connectivity analysis (Anticevic et al., 2012a) (16 articles excluded).
(8) Articles that did not report whole brain results (nine articles excluded).
2.2. Studies included into the ALE meta-analysis
A total of 19 studies were included in the ALE meta-analysis with a total of 316
patients with schizophrenia (214 males) and 299 healthy controls (186 males) (see
details in Table 1). There were 107 foci from 14 studies (anticipatory pleasure:11
foci from four studies; consummatory pleasure: 96 foci from 10 studies) that were
included in the meta-analysis statistically comparing regions where schizophrenia
patients had signiﬁcantly decreased brain activation relative to healthy controls
(healthy controls (HC)4schizophrenia (Sz)), and 19 foci from four studies (antici-
patory pleasure: 0 study; consummatory pleasure: 19 foci from four studies) were
included to examine the reverse contrast (Sz4HC). Eight studies reported activa-
tion with a total of 55 foci (anticipatory pleasure: ﬁve foci from three studies;
consummatory pleasure: 50 foci from six studies) for schizophrenia patients alone
while 10 studies reported activation with a total of 122 foci (anticipatory pleasure:
56 foci from six studies; consummatory pleasure: 66 foci from seven studies) for
healthy controls alone. We performed ALE analysis for anticipatory and consum-
matory pleasure contrasts, respectively.
Since the analyses were conducted in Talairach space, activation coordinates
which were originally reported in Montreal Neurological Institute (MNI) coordi-
nates were converted using Lancaster’s transform before the ALE analysis. For
articles using Brett’s formulation to convert from MNI to Talairach, the data was
ﬁrst converted back to MNI coordinates using Brett’s transform, and then
transformed into Talairach space using Lancaster’s transform.
2.3. Activation likelihood estimation
A random-effects meta-analysis was carried out using the up-to-date version of
the GingerALE software (GingerALE 2.3.1) (Turkeltaub et al., 2002; Laird et al., 2005;
Eickhoff et al., 2009). The idea behind the ALE analysis is that the peak coordinates
reported in studies should be viewed as probability distributions around themselves
(Turkeltaub et al., 2002). In practical terms, an ALE map was constructed based on foci
from studies included, and then convolved with a 3D Gaussian kernel. We chose to
use the ALE algorithm described by Eickhoff et al. (2009). In this algorithm, full-width
at half-maximum (FWHM) was automatically provided to compute the ALE value
Table 1
Summary of articles included in the meta-analysis (19 published imaging studies including 316 schizophrenia patients and 299 healthy controls).
No. Articles Imaging device Task instruction Stimuli Sample size
(Sz–HC)
% Male Age Sz % Drug Estimated NS Pleasure type Contrast
1 Crespo-Facorro et al. (2001) PET Stimuli Odorant 18-16 68 30.00 0 0.51n Consummatory √a, b
2 Gur et al. (2002) fMRI Stimuli Face 14-14 71 28.80 93 0.32 Consummatory √a, c, d
3 Paradiso et al. (2003) PET Stimuli Pictures 18-17 66 30.00 0 0.51n Consummatory √a, b
4 Taylor et al. (2005) PET Stimuli Pictures 18-10 61 33.02 75 0.32 Consummatory √a, c, d
5 Juckel et al. (2006b) fMRI Feeling Money 10-10 100 26.80 0 0.47n Anticipatory √a, d
6 Reske et al. (2007) fMRI Feeling Pictures 10-10 60 37.40 100 0.30 Consummatory √a, b
7 Schlagenhauf et al. (2008) fMRI Feeling Money 10-10 90 30.50 100 0.44n Anticipatory √a, c, d
8 Schlagenhauf et al. (2009) fMRI Feeling Money 15-15 63 30.10 0 0.54n Anticipatory √d
Consummatory √d
9 Walter et al. (2009) fMRI Feeling Money 16-16 47 38.00 100 0.45n Anticipatory √a, c, d
Consummatory √b, c, d
10 Waltz et al. (2009) fMRI Feeling Drink 18-18 75 37.70 100 0.19 Consummatory √a
11 Simon et al. (2010) fMRI Feeling Money 15-15 67 26.30 100 0.37n Anticipatory √d
Consummatory √c, d
12 Gradin et al. (2011) fMRI Feeling Water 14-17 58 42.50 60 0.25 Anticipatory √c, d
13 Holt et al. (2011) fMRI Stimuli Sentence 14-18 82 42.90 79 0.31 Consummatory √a
14 Morris et al. (2012) fMRI Feeling Money 16-16 53 33.00 100 0.28 Consummatory √c, d
15 Surguladze et al. (2011) fMRI Stimuli Face 32-16 53.1 43.15 100 0.21 Consummatory √c, d
16 Koch et al. (2010) fMRI Feeling Money 19-20 61.5 35.20 94.7 0.38n Consummatory √a
17 Li et al. (2010) fMRI Stimuli Face 12-12 50 29.80 100 0.27 Consummatory √a
18 da Silva Alves et al. (2013) fMRI Feeling Money 10-12 100 22.70 100 0.29 Anticipatory √a
19 Lakis and Mendrek (2013) fMRI Feeling Pictures 37-37 51 32.46 100 0.26 Consummatory √a
Note: Sz¼schizophrenia; HC¼healthy controls; Stimuli¼stimuli oriented task requiring participants to response to the emotional stimuli itself (i.e. happy facial expression);
Feeling¼feeling oriented task using emotional stimuli to evoke participants’ mood.
a HC4Sz.
b Sz4HC.
c Sz alone.
d HC alone; NS¼negative symptom.
n Indicated elevated level of negative symptom.
Fig. 1. The ﬂow chart for the meta-analysis.
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based on the number of subjects recruited. Lastly, GingerALE performed cluster
analysis on the threshold map, based on the minimum volume that is speciﬁed in the
previous step. Clusters identiﬁed in the meta-analysis were obtained after controlling
for the false discovery rate (FDR) at po0.05 and applying a minimum cluster size of
200 mm3 (about 7 voxels with size of 333 mm). The reason for applying this
cluster threshold was to lower the false-positive error rate. This threshold has been
frequently used in previous studies (Li et al., 2010; Jardri et al., 2011; Sugranyes et al.,
2011). The brain maps of ALE values were imported to mango software 2.4 (http://ric.
uthscsa.edu/mango/).
A number of confounding factors such as medication status, severity of
negative symptoms, task instruction type, and stimulus characteristics might affect
the neurobiological activity associated with hedonic experience in schizophrenia
(da Silva Alves et al., 2008; Barch and Dowd, 2010; Kring and Caponigro, 2010). We
performed subsidiary analyses (HC4Sz, and Sz4HC contrasts) for neural
responses in medicated (deﬁned as all the patients taking antipsychotic medica-
tions) and unmedicated schizophrenia patients (deﬁned as 0% patients taking
antipsychotic medication) compared with healthy controls. For negative symptoms,
the symptom score in each study was transformed ﬁrst by dividing the total score
of the negative symptom scale used in that study (Yan et al., 2012). Then we
averaged the transformed score of all the studies. If the transformed score in one
study was higher than the averaged score, this study was considered as a study
recruiting patients with relatively elevated negative symptoms, and vice versa.
Since the averaged score of the present study was 0.35, which was within the range
of the established cut-off score in previous studies (transformed cut-off score: from
0.22 to 0.38) (Bell et al., 2013; Gold et al., 2013; Oorschot et al., 2013), our high/low
categorization was considered valid. Similar subsidiary analyses were performed
for these two types of studies. For task instruction type, since different task
instructions (feeling-oriented vs. stimuli-oriented) might activate different parts of
the medial prefrontal cortex (dorsal/rostral vs. ventral) (Ochsner et al., 2004;
Olsson and Ochsner, 2008), this factor was also taken into consideration. Stimuli-
oriented tasks required participants to rate the emotional stimulus itself. On the
other hand, feeling-oriented tasks required participants to provide their feelings
about or be passively exposed to emotional stimuli. Lastly, we also performed
subsidiary analyses on studies using different kinds of stimuli such as positively
valenced pictures, money, odourants, drinks, faces, and words.
3. Results
3.1. Contrast of anticipatory, and consummatory pleasure
3.1.1. Consummatory pleasure
For healthy controls alone, seven studies reported activation,
resulting in 66 foci. ALE scores and cluster size in these brain
locations are summarized in Table 2 and Fig. 2. Healthy controls
activated the left amygdala, the pregenual anterior cingulate
cortex (pgACC, BA 32), the left putamen, the left insula (BA 13),
the medial prefrontal cortex (mPFC, BA 6), and the right red
nucleus (RN) (when consummating pleasure).
For schizophrenia patients, 50 foci from six studies revealed
signiﬁcant activations associated with positive emotion (see
Table 2 and Fig. 2 for details of ALE value and cluster size). It
yielded four clusters indicating activation at the left postcentral
gyrus (PostG, BA 3), the left insula (BA 13), the right fusiform gyrus
(FG, BA 19), and the left declive during consummatory pleasure
processing in schizophrenia patients.
For the group contrast of HC4Sz, 10 studies reported a total of 96
foci of relative decrease in activation in schizophrenia patients
compared with healthy controls. The brain map, ALE value, and cluster
size are presented in Table 2 and Fig. 3. It consistently revealed eight
clusters indicating activation reductions in the rostral medial prefron-
tal cortex (rmPFC, BA 9), the right parahippocampal gyrus/amygdala
(BA 20), the left precental gyrus (PreG, BA 6), the left putamen, the
right inferior frontal gyrus (IFG, BA 9), the left middle temproal gyrus
(MTG, BA 21),the left medial globus pallidus (MGP), and the subgenual
ACC (sgACC, BA 32) in schizophrenia patients relative to healthy
controls. Activation in the rmPFC remained signiﬁcant when we
applied a more conservative statistic threshold of FDR-corrected
p-value o0.01 and a minimum cluster size of 200 mm3.
For the group contrast of Sz4HC, four studies found a total of
19 foci of relative increase in activation at the right culmen in Sz
patients compared with HC, although the number of studies was
small (Table 2 and Fig. 3).
3.1.2. Anticipatory pleasure
As expected, 55 foci from six studies revealed enhanced
acitivation in the right caudate head, the left lateral globus
pallidus, and the red neucleus (RN) associated with anticipatory
pleasure in healthy samples (see Table 2 and Fig. 2).
For the group contrast of HC4Sz, four studies found a total of
11 foci of relative decrease in activation in schizophrenia patients
compared with healthy controls. It revealed only one cluster
indicating an activation reduction in the left putamen in patients
with schizophrenia (see Table 2 and Fig. 3).
For schizophrenia patients alone and the group contrast of
Sz4HC, the number of studies and foci was too small for mean-
ingful ALE analysis.
3.2. Confounding factors
For anticipatory pleasure, since the number of studies with
between-group contrasts was small, we were not able to perform
the subsidiary analyses on all four confoundings factors. Here, we
mainly reported the ﬁndings of confounding factor analysis for
consummatory pleasure. Eleven studies included between-group
contrasts (either HC4Sz or Sz4HC).
3.2.1. Task instruction
Studies using a feeling-oriented task (n of study¼4; n of
foci¼50) demonstrated attenuated activation in the rmPFC (BA
9) and the left putamen in Sz patients. On the other hand, studies
using stimuli-oriented tasks (n of study¼6; n of foci¼46) showed
decreased activation in the sgACC (BA 32), the left MGP, and the
anterior middle cingulate cortex (aMCC, BA 32) in patients with Sz
compared with HC (Table 3).
3.2.2. Medication status, negative symptoms and stimulus type
For these three confounding factors, due to the limited number
of studies, confounding analyses were asymmetrical. For example,
studies including patients taking medications (n¼4) and with a
mild level of negative symptoms (n¼7) both demonstrated
reduced activation in the left PreG (BA 6) and the left MTG.
However, for studies comprising unmedicated patients and
patients with a high level of negative symptoms, the number of
studies (unmedicated: n¼2; high level of negative symptoms:
n¼3) were too small for meaningful analyses for the Sz4HC or
HC4Sz comparison. For stimulus type, we attempted to sepe-
rately perform analyses for studies using pictures, faces, money,
words, drinks, and odourants as stimuli. However, the number of
studies for almost all types of stimuli was also too small to perform
subsidiary analyses.
4. Discussion
The present meta-analysis showed that schizophrenia patients
exhibited reduced activation associated with consummatory plea-
sure mainly in the rmPFC (BA 9), the right parahippocampal gyrus/
amygdala and other related regions such as the left PreG (BA 6),
the right IFG (BA 9), the sgACC, the left MTG (BA 21), the left
putamen, and the left MGP compared with healthy controls.
Attenuated activation in the left putamen was found in patients
with schizophrenia when processing anticipatory pleasure relative
to healthy controls. For consummatory pleasure, dsyfunction in
the rmPFC and the sgACC in schizophrenia was differetially elicited
by feeling-oriented instructions and stimuli-oriented instructions.
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Table 2
ALE results of neural response abnormality for consummatory and anticipatory pleasure contrasts (p(FDR-corrected)o0.05; volume size 4200 mm3).
Group
contrast
Pleasure type Foci
Num.
Cluster
Num.
Regions label BA Volume Peak
ALE
Talairach
coordinates
Contributed
Num. of
foci
x y z
HC4Sz Anticipatory pleasure5, 7, 9, 18 (N¼4) 11 1n L. putamen 816 0.011 18 10 0 3
Consummatory pleasure1, 2, 3, 4, 6, 10, 13, 16,
17, 19 (N¼10)
96 1n rmPFC 9 824 0.02 12 44 18 3
2 L. PreG 6 584 0.015 36 4 30 3
3 L. putamen 368 0.014 22 10 12 2
4 R.IFG 9 360 0.013 48 12 26 2
5 R. parahippocampal gyrus/
amygdala
20 352 0.014 40 18 20 2
6 L.MTG 21 296 0.009 56 32 6 3
7 L.MGP 280 0.012 14 6 8 2
8 sgACC 32/
11
272 0.012 6 32 10 2
Sz4HC Anticipatory pleasure (N¼0) 0 –
Consummatory pleasure1, 3, 6, 9 (N¼4) 19 1n R. culmen 416 0.011 0 56 22 2
Sz alone Anticipatory pleasure7, 9, 12 (N¼3) 5 –
Consummatory pleasure2, 4, 9, 11, 14, 15
(N¼6)
50 1n L. PostG 3 832 0.021 36 28 48 4
2 L. insula 13 416 0.013 32 22 6 3
3 R. fusiform gyrus 19 352 0.015 36 70 12 2
4 L. declive 200 0.013 36 78 16 2
HC alone Anticipatory pleasure5, 7, 8, 9, 11, 12 (N¼6) 55 1n R. caudate head 3064 0.035 10 4 2 11
2n L. LGP 1944 0.027 16 4 0 7
3n R. RN 896 0.018 6 24 8 4
Consummatory pleasure2, 4, 8, 9, 11, 14, 15
(N¼7)
66 1n L. amygdala 1400 0.026 20 6 10 5
2 pgACC 32 432 0.016 2 44 2 3
3 L. putamen 232 0.014 18 6 0 2
4 L. inusla 13 224 0.013 30 20 6 2
5 mPFC 6 224 0.013 2 6 48 2
6 R. RN 216 0.014 4 22 8 2
Note: R.¼right; L.¼ left; Sz¼schizophrenia; HC¼healthy control; N¼number of studies involved in the ALE analysis; rmPFC¼rostral medial prefrontal cortex; IFG¼ inferior
frontal gyrus; PreG¼precentral gyrus; MTG¼middle temporal gyrus; sgACC¼subgenual anterior cingulate cortex; pgACC¼pregenual anterior cingulate cortex;
postG¼postcentral gyrus; LGP¼ lateral globus pallidus; RN¼red neucleus; SN¼substania nigra.; “” refers that we did not perform the subsidiary analysis because of
the number of studies was less than four.
n Refers that the ﬁndings remained signiﬁcant after a more conservative correction (po0.01 FDR-corrected, cluster size 4200 mm3); the number listed beside the
pleasure type (i.e. Anticipatory Pleasure) refers to the serial number of study listed in Table 1.
Fig. 2. Results from an activation likelihood estimation meta-analysis of studies investigating neural response changes related with consummatory and anticipatory pleasure
in healthy controls and schizophrenia alone, respectively. Light regions represent increasing brain activity in the contrast of consummatory and anticipatory pleasure in
healthy controls and schizophrenia patients, respectively.
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4.1. Consummatory pleasure dysfunction in schizophrenia
4.1.1. Reduced rostral medial prefrontal activation in schizophrenia
In our study, deceased activation in the rmPFC, which has been
considered by Knutson and his colleagues as a key brain region
involved in “in the moment” hedonic processing or positive
feedback (Knutson et al., 2003; Knutson and Greer, 2008), was
robustly observed in patients with schizophrenia. Similar to our
ﬁnding, medial prefrontal dysfunction was also observed in pre-
vious studies mainly investigating consummatory negative emo-
tions in patients with schizophrenia (Taylor et al., 2012) and
especially in those with blunted affect (Fahim et al., 2005; Stip
et al., 2005). In Taylor’s recent meta-analysis (Taylor et al., 2012),
121 foci from 28 contrasts for general negative emotions were
included. The meta-analysis revealed that schizophrenia patients
exhibited attenuated neural activation in the right dorsal medial
frontal gyrus (BA 32), the right medial prefrontal gyrus (BA 6) and
bilateral anterior cingulate (BA 24 and BA 32) during negative
emotion processing. Our study underscores that the medial pre-
frontal cortex plays an important role in the consummatory
processing of both positive and negative information. It is of
interest, however, that the rmPFC in this study is distinct from
those regions reported in the study of Taylor et al. Speciﬁcally,
deﬁcit in consummatory pleasure in schizophrenia patients might
be represented rostrally in the mPFC, whereas consummtory
negative emotion might be represented more dorsally in the
mPFC. Dissociable dysfunction in the rostral and dorsal mPFC
might improve our understanding of the neural correlates of the
consummatory emotional deﬁcit in schizophrenia and provide
clues for intervention of negative symptoms (e.g., repetitive
transcranial magnetic stimulation (rTMS) in schizophrenia
(Dlabac-de Lange et al., 2010).
From the behavioural perspective, a number of previous narrative
reviews and meta-analyses did not ﬁnd signiﬁcant differences in
pleasantness or arousal rating to positive stimuli between schizo-
phrenia patients and healthy controls (Kring and Moran, 2008; Cohen
and Minor, 2010; Cohen et al., 2010; Kring and Caponigro, 2010; Yan
et al., 2012). Two factors might account for the difference between
ﬁndings from behavioural and imaging studies. One is that fMRI may
be a more sensitive tool than behavioural assessments to detect the
affective dysfunction in schizophrenia. The other possibility is that
there may be a compensatory neural mechanism which is able to
Fig. 3. Results from an activation likelihood estimation meta-analysis of studies investigating neural response changes related with consummatory and anticipatory pleasure
in healthy controls compared with schizophrenia and vise versa. Light regions represent brain activity decrease in patients with schizophrenia relative to healthy comparison
participants. Dark regions represent brain activity increase in patients with schizophrenia relative to healthy controls.
Table 3
ALE results for consummatory pleasure contrasts (including HC4Sz and Sz4HC) within confounding factors (i.e. task instruction (feeling oriented/stimuli oriented))
(pFDRo0.05; volume size 4200 mm3).
Confounding factors Group contrast Foci Num. Cluster Num. Regions label BA Volume (mm3) Peak ALE Talairach coordinates
x y z
Task Feeling HC4Sz6, 10, 16, 19 (N¼4) 50 1n rmPFC 9 840 0.020 12 44 18
Instruction Oriented 2 L. putamen 432 0.014 22 10 12
Sz4HC6, 9 (N¼2) 2 –
Stimuli HC4Sz1, 2, 3, 4, 13, 17 (N¼6) 46 1 L. MGP 424 0.012 14 6 8
Oriented 2 sgACC/vmPFC 32/11 392 0.011 6 32 10
3 aMCC 32 272 0.009 2 30 32
Sz4HC1, 3 (N¼2) 17 –
Note: R.¼right; L.¼ left; Sz¼schizophrenia; HC¼healthy control; N¼number of studies involved in the ALE analysis; rmPFC¼rostral medial prefrontal cortex; MGP¼medial
globus pallidus; sgACC¼subgenual anterior cingulate cortex; aMCC¼anterior middle cingulate cortex; “” refers that we did not perform the subsidiary analysis because of
the number of studies was less than four.
n Refers that the ﬁndings remained signiﬁcant after a more conservative correction (po0.01 FDR-corrected, cluster size 4200 mm3); the number listed beside the group
contrast refers to the serial number of study listed in Table 1.
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account for the seemingly intact behavioural response to positive
stimuli in patients with schizophrenia when there is an underlying
activation deﬁcit detectable only by fMRI. In this study, we observed
that schizophrenia patients showed enhanced activation at the right
culmen, which plays an important role in emotional experience
(Schmahmann, 2000; Goel and Dolan, 2001; Turner et al., 2007).
Moreover, previous studies have found that schizophrenia patients
showed increased activation in the cerebellum but decreased activa-
tion in the prefrontal gyrus (Andreasen et al., 1997; Stip et al., 2005),
which suggests the presence of compensatory mechanisms in various
cortical and subcortical (including cerebellar) circuits.
4.1.2. Attenuated amygdala activation in schizophrenia
We observed decreased amygdala activation with consummatory
pleasure in patients with schizophrenia compared with healthy
controls. Consistent with our ﬁndings on positive affect, a number
of previous studies have traditionally suggested that schizophrenia
patients exhibit decreased amygdala activation during negative
affective processing (Shayegan and Stahl, 2005; Rosenfeld et al.,
2011; Anticevic et al., 2012b). For example, in one meta-analysis (not
ALE), Anticevic et al. (2012b) speciﬁcally focused on amygdala
function and found that patients with schizophrenia showed mod-
erate under-recruitment of bilateral amygdala (effect size¼0.20) in
response to aversive emotional stimuli, suggesting that under-
recruitment of the amygdala might underlie the neural mechanism
of consummatory affective processing in schizophrenia. Consistent
with this hypothesis, another meta-analysis by Li et al. (2010)
speciﬁcally measured the neural response to facial emotion in
patients with schizophrenia and found decreased activation in
bilateral amygdala (ALE value¼0.052 to 0.060; cluster size¼272 to
368 mm3). Furthermore, failure of amygdala activation has been
observed in patients with schizophrenia during the performance of
both explicit and implicit tasks (an explicit design refers to tasks
directly requiring participants to discriminate, judge, or evaluate the
property of a facial expression; an implicit design refers to tasks
indirectly measuring patients’ emotion processing by asking them to
evaluate the unrelated properties of a stimulus (e.g., gender, age
detection). Meanwhile, a number of structural MRI studies have also
observed signiﬁcant bilateral reduction of amygdala volume (6–10%)
in schizophrenia patients compared with healthy controls (Lawrie
and Abukmeil, 1998; Wright et al., 2000), which might establish an
important role for the amygdala in understanding the affective deﬁcit
in consummatory pleasure experience in patients with schizophre-
nia. However, the impact of anhedonic symptoms on amygdala
activity during hedonic experience processing (Barch and Dowd,
2010) should also be noted because some studies did not report
signiﬁcantly decreased activity in this region in patients with
schizophrenia (Paradiso et al., 2003; Reske et al., 2007; Dowd and
Barch, 2010). For example, Dowd and Barch (2010) reported intact
amgydala response to positively valenced stimuli in schizophrenia
patients, but they did ﬁnd that the magnitude of this response was
negatively correlated with the physical anhedonia score. Therefore,
more research his needed to speciﬁcally delineate how negative
symptoms of schizophrenia like anhedonia modulate activation in
these brain regions.
Decreased activations were also observed in other brain regions
such as the sgACC, the putamen, and the MGP, all of which have
been considered important limbic hot spots in the processing of
consummatory pleasure in healthy controls (Knutson and Greer,
2008; Kringelbach and Berridge, 2009). In line with this ﬁnding,
one recent review has stated that patients with schizophrenia
exhibited dysfunction in the limbic system (i.e., the anterior
cingulate cortex, the orbitofrontal cortex, and the striatum) in
response to positive stimuli, even though these results were mixed
with an equal number of studies ﬁnding intact activation in these
regions (Kring and Barch, 2014). In addition, cognitive processing
(i.e., cognitive control and affective maintenance) might contribute
to the ﬁnding of differences in activation of the ACC in patients
with schizophrenia (Kring and Barch, 2014; Ursu et al., 2011).
Taken together, the ﬁndings suggest that limbic functional
abnormality might also play arole in consummatory pleasure
processing in schizophrenia.
4.1.3. Confounding factors
For task instruction, our subsequent confounding factor analysis
showed that patients with schizophrenia exhibited reduced activa-
tion in the rmPFC in studies with feeling-oriented instructions. It
suggests that studies using feeling-oriented instructions might
contribute to the rmPFC dysfunction during processing of consum-
matory pleasure in patients with schizophrenia. As is known, the
mPFC has been considered a key brain region where activation is
correlated with consummatory pleasure in healthy populations
(Knutson and Greer, 2008). Furthermore, reporting on feeling of
one’s own feeling has been found to be associated with dorsal/
rostral mPFC activation (Ochsner et al., 2004; Olsson and Ochsner,
2008). Patients with schizophrenia have been found to have difﬁ-
culty in identifying and describing their own feeling compared with
their unaffected siblings and healthy controls (van ‘t Wout et al.,
2007; Kimhy et al., 2012). One functional neuroimaging study has
found that patients with schizophrenia showed similar hypoactiva-
tion in the rostral/dorsal mPFC during self-evaluation of their own
emotional, mental and physical traits (relative to evaluating the
traits of others) (Bedford et al., 2012). From the perspective of brain
structure, one multimodal neuroimaging study combining both
voxel-based morphometry (VBM) and diffusion tensor imaging
(DTI) to detect grey matter volume and white matter integrity and
connectivity identiﬁed the medial prefrontal cortex as a prominent
site of abnormality in schizophrenia. This region also corresponds to
the anterior midline node of the default mode network, a brain
system which is believed to support the maintenance of one’s sense
of self (Pomarol-Clotet et al., 2010).
On the other hand, our subsidiary analysis for studies employ-
ing stimulus-oriented instructions showed that patients with
schizophrenia had attenuated activation in cortical regions such
as the sgACC when they were required to report on affective
properties of the stimuli. Since the sgACC is located adjacent to the
ventral portion of the mPFC, its activation is more likely to be
associated with reporting on the affective properties of a stimulus
(Ochsner et al., 2004; Olsson and Ochsner, 2008). Previous studies
have suggested that patients with schizophrenia may have difﬁ-
culties in distinguishing properties of emotional stimuli (e.g., facial
emotion; see meta-analysis in Kohler et al., 2010). Therefore, this
might partially explain the observation of sgACC dysfunction
during reporting of the affective properties of a stimulus. Taken
together, in line with the hypothesis by Kring and Elis (2013),
Kring and Moran (2008), our ﬁnding supports the differential role
of task instruction in measuring mPFC dysfunction associated with
consummatory pleasure in patients with schizophrenia.
4.2. Altered striatal response associated with anticipatory pleasure
in schizophrenia
Recently, more and more researchers have suggested that
impairment in anticipatory pleasure experience might underlie
the phenomenon of anhedonia in schizophrenia (Kring and
Caponigro, 2010; Cohen et al., 2011). The striatum, including the
ventral and dorsal striatum, is critical for reward prediction/
anticipatory pleasure (Groenewegen and Trimble, 2007; Knutson
and Greer, 2008). At the level of brain morphometry in schizo-
phrenia, numerous studies have found reduced grey matter
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volume in the ventral and dorsal striatum in patients with
schizophrenia (Gaser et al., 2004; Mamah et al., 2007), including
medication-naïve patients (Keshavan et al., 1998; Ebdrup et al.,
2010). In fMRI studies, there is growing evidence suggesting that
activation in the striatum reﬂecting reward prediction/wanting
may be affected in schizophrenia patients (Barch and Dowd, 2010).
Consistent with these ﬁndings, our results indicate activation
reduction in the left putamen (dorsal striatum) during anticipatory
pleasure processing in schizophrenia. However, we did not
observe decreased ventral striatal activation in patients with
schizophrenia. One reason to explain this negative ﬁnding is the
small number of studies reporting ﬁndings using whole brain
analysis. A number of previous neuroimaging studies analyzed
regions of interest (ROIs) and performed the between-group
contrast in a pre-deﬁned region (such as ventral striatum)
(Juckel et al., 2006a; Schlagenhauf et al., 2009; Gradin et al.,
2011). As is known, these ROI studies are not amenable to ALE
analysis. Our ALE analysis only included four studies with 11 foci
reporting group comparison contrasts (HC4Sz). Therefore, more
work is needed before any conclusion can be made about the role
of the striatal region in anticipatory pleasure dysfunction in
schizophrenia. For example, it is worthwhile to investigate how
negative symptoms moderate activation in the striatal region
during the processing of anticipatory pleasure in schizophrenia.
On the other hand, social anhedonia has been considered a
potential vulnerability marker for schizophrenia spectrum disor-
ders (Meehl, 1990; Kwapil, 1998). As far as we know, no study has
examined the neural basis of anticipatory pleasure in schizophre-
nia in the social interaction context. More studies are needed to
examine the neural response associated with anticipatory pleasure
carrying social information in schizophrenia patients to improve
our understanding of social anhedonia and social withdrawal in
schizophrenia.
4.3. Limitations
There are several limitations in the present study. First, relative
to HC4Sz comparison, the Sz4HC comparison yielded only four
studies for consummatory pleasure and no study for anticipatory
pleasure, suggesting that our meta-analytic study might be better
able to identify reduced rather than increased activation in
patients with schizophrenia. Similar asymmetries were also pre-
sent in the subsidiary analyses. We originally intended to ﬁnd out
how stimulus type, level of negative symptoms, and medication
affect neural activation associated with consummatory pleasure in
schizophrenia patients, but the number of studies for each con-
founding factor was too small for meaningful analysis. Second,
since only positive ﬁndings could be applied to ALE analysis, some
negative ﬁndings were inevitably excluded in our analysis. More-
over, ALE does not readily allow for multiple regression analysis to
tease out the separate inﬂuences of different variables (such as
medication status and negative symptom). More sophisticated
methods of analysis combining both behavioural and imaging data
should be developed to examine the underlying mechanism of
hedonic experience in schizoophrenia. Third, we acknowledge the
possibility that the predominance of males in the included studies
might have biased the results.
5. Conclusion
Taken together, our ﬁndings suggest that the medial prefrontal
cortex and the limbic regions may play an important role in the
neural dysfunction associated with consummatory pleasure pro-
cessing and support the differential role of task instruction in
affecting mPFC dysfunction in schizophrenia. It may provide
researchers relatively solid evidence to understand the neural
correlates of anhedonia (especially consummatory pleasure) in
schizophrenia and to develop more effective and speciﬁc clinical
interventions (such as repetitive transcranial magnetic stimulation
or real-time fMRI training) to alleviate negative symptoms in
schizophrenia.
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